Arnout Everaert

Arnout Everaert is Head of Drug Product Europe at Ardena, where he leads the company’s drug product development and manufacturing strategy across its European operations. He is responsible for advancing Ardena’s integrated service offering, strengthening operational alignment between sites, and supporting the company’s continued growth as a leading CDMO.

Arnout holds a PhD in Pharmaceutical Sciences. He brings extensive experience in formulation development, CMC strategy, and GMP manufacturing, with a strong track record in guiding complex drug products from development through clinical supply. Since joining Ardena in 2017, he has held several senior leadership roles, most recently serving as Business Unit Director at the Ghent site.

As a member of the leadership team, Arnout focuses on driving strategic initiatives, fostering collaboration across functions and geographies, and ensuring Ardena continues to deliver high-quality, scientifically driven solutions to its clients.

Ariane De Ganck, PhD

Since 2019, Ariane has overseen Ardena’s drug product activities, spearheading successful integration and transformation at Ardena Pamplona and expanding the company’s capabilities to include sterile services.

With over a decade of senior management experience in CRO/CDMO sectors, Ariane excels in leading multidisciplinary teams and is dedicated to team development, fostering networks, and maintaining a customer-centric approach. Her leadership has also been instrumental in driving business development initiatives.

Prior to joining Ardena, Ariane made significant contributions to the growth of Biogazelle, a specialized CRO in RNA and DNA biomarker services.

Ariane holds a PhD in biomedical sciences, focusing on proteins and oncology